tirzepatide once weekly In adults with obesity but not diabetes, leads to significantly greater weight loss than semaglutide over 72 weeks, and nearly double the patients on tirzepatide meet the 25% weight-loss target. http://ms.spr.ly/6183SkuIL ✨ Tirzepatide is a once‑weekly

Country of Origin: Made in the USA with globally sourced ingredients

You could also download a reminder app on your phone

If affordability is a concern, talk to your doctor about: Lower-cost alternatives including older oral medications we keep in stock at the clinic (phentermine, diethylpropion, Contrave, and others) Dose optimization staying on the lowest effective dose Patient assistance programs through the manufacturer Splitting strategies for some injectable pens at higher doses For a broader look at how CNC approaches pricing and insurance: Insurance, Cost & Medication Access

She shares coding tips from an auditors perspective, highlighting common pitfalls and practical ways coders and CDI teams can improve accuracy and documentation quality